S2G Investments
S2G Ventures is a venture capital firm based in Chicago, established in 2014, that focuses on investing in the food and agriculture sectors. The firm aims to support entrepreneurs whose products and services address the growing consumer demand for healthy, sustainable, and locally sourced food. S2G Ventures identifies key areas within the food system that are poised for innovation and change, creating a diverse portfolio that includes seed, venture, and growth-stage investments. Its investment interests span various domains, including agriculture, ingredients, infrastructure and logistics, food safety and technology, retail and restaurants, and consumer brands.
AquaConnect
Series B in 2024
Aquaconnect is a comprehensive aquaculture platform established in 2017 that supports fish and shrimp farmers in enhancing productivity and financial access through innovative technology solutions. By leveraging AI and satellite remote sensing, Aquaconnect captures pond data to deliver data-driven advisory services, enabling farmers to optimize water quality, aquatic health, and feed consumption. The platform facilitates connections between farmers and key stakeholders in the aquaculture value chain, including feed producers, equipment manufacturers, banks, and insurers. With an integrated approach, Aquaconnect has assisted over 60,000 farmers, providing them with context-aware alerts and suggestions to improve their operations. Additionally, the company offers data-enabled fintech solutions that enhance transparency for financial stakeholders engaging with the aquaculture community, ultimately helping to improve market linkages and value realization for farmers.
ViAqua Therapeutics
Venture Round in 2023
ViAqua Therapeutics Ltd is an Israeli company founded in 2014 that specializes in developing innovative drugs and therapeutics for the aquaculture industry. The company focuses on creating the first orally administered treatment designed to combat viral diseases affecting aquatic species, particularly shrimp. ViAqua's proprietary platform employs a unique RNAi nanoparticle formulation that triggers a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion techniques, enhancing the resistance of aquaculture species against viral epidemics. With a management team experienced in business development and industrial biotechnology, ViAqua aims to improve the health and sustainability of aquaculture practices.
ReelData AI
Series A in 2023
ReelData AI specializes in developing artificial intelligence software tailored for the aquaculture industry. Based in Halifax, Canada, the company offers advanced monitoring solutions for fish farms, utilizing feed cameras to measure key metrics such as biomass, sea lice presence, and overall fish health in real-time. This technology enables fish farms to optimize their operations by providing crucial insights into weight distributions, feeding patterns, and growth analysis. By improving the efficiency of feed usage and enhancing fish health, ReelData AI aims to support aquaculture businesses in maximizing their productivity and sustainability. The company was established in 2019.
Avant Meats
Venture Round in 2022
Avant Meats is a biotechnology company specializing in the production of cell-based animal protein products, particularly fish and marine proteins. The company has developed an innovative platform that allows for the creation of nutritious and flavorful fish proteins directly from fish cells, eliminating the need for traditional methods such as raising, catching, or slaughtering animals. This approach enables the sustainable cultivation of animal-free proteins in a controlled environment, ensuring that the products are free from pollutants. Avant Meats aims to provide consumers with sustainable protein options for food, skincare, and functional applications, while also focusing on technology, product innovation, and the development of a robust intellectual property portfolio.
ViAqua Therapeutics
Venture Round in 2021
ViAqua Therapeutics Ltd is an Israeli company founded in 2014 that specializes in developing innovative drugs and therapeutics for the aquaculture industry. The company focuses on creating the first orally administered treatment designed to combat viral diseases affecting aquatic species, particularly shrimp. ViAqua's proprietary platform employs a unique RNAi nanoparticle formulation that triggers a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion techniques, enhancing the resistance of aquaculture species against viral epidemics. With a management team experienced in business development and industrial biotechnology, ViAqua aims to improve the health and sustainability of aquaculture practices.
ReelData AI
Seed Round in 2021
ReelData AI specializes in developing artificial intelligence software tailored for the aquaculture industry. Based in Halifax, Canada, the company offers advanced monitoring solutions for fish farms, utilizing feed cameras to measure key metrics such as biomass, sea lice presence, and overall fish health in real-time. This technology enables fish farms to optimize their operations by providing crucial insights into weight distributions, feeding patterns, and growth analysis. By improving the efficiency of feed usage and enhancing fish health, ReelData AI aims to support aquaculture businesses in maximizing their productivity and sustainability. The company was established in 2019.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.